The results of the study (presented in Fig. 1) showed that survivin gene BIRC5 was expressed at significantly higher levels in the thyroid cancers (P = 0,0232), than in benign thyroid nodules. The gene discussed is BIRC5; the disease is thyroid gland carcinoma.